“Silymarin-choline combination versus ursodeoxycholic acid in non-alcoholic fatty liver disease: A randomized double-blind clinical trial” (2024) Asian Journal of Medical Sciences, 15(4), pp. 70–77. doi:10.3126/ajms.v15i4.61970.